Position in NVO
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,315,377
+$307,031 QoQ
Shares Held
27,438
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#459
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WOODMONT INVESTMENT COUNSEL LLC holds $91,634,066 across 9 Drug Manufacturers - General names. NVO ranks #7 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
22,183 | $26,606,957 | |
| 2 | JNJ |
Johnson & Johnson
|
92,061 | $23,380,732 | |
| 3 | MRK |
Merck & Co., Inc.
|
173,179 | $22,253,501 | |
| 4 | PFE |
Pfizer Inc
|
284,542 | $6,851,771 | |
| 5 | ABBV |
AbbVie Inc.
|
22,718 | $5,716,757 | |
| 6 | NVS |
Novartis AG
|
27,118 | $4,249,932 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
27,438 | $1,315,377 | |
| 8 | AMGN |
Amgen Inc
|
1,805 | $653,626 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,315,377 | 27,438 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $1,008,346 | 27,438 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,784,056 | 35,064 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $2,026,661 | 36,523 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,594,392 | 37,589 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $8,223,223 | 118,422 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $9,509,597 | 110,551 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $3,499,229 | 29,388 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $4,194,843 | 29,388 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $3,626,016 | 28,240 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $2,890,393 | 27,940 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $2,483,389 | 27,308 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $2,209,626 | 13,654 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $2,247,534 | 14,123 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $1,843,736 | 13,623 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $1,357,259 | 13,623 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,491,267 | 13,383 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,486,182 | 13,383 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,498,896 | 13,383 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $1,286,149 | 13,396 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,122,182 | 13,396 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $902,281 | 13,383 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $934,802 | 13,383 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,379,365 | 19,867 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,300,891 | 19,867 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,195,993 | 19,867 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||